Fasciitis in mixed connective tissue disease successfully treated with high-dose intravenous immunoglobulin

Internal Medicine

Volumn 42, Issue 9, 2003, Pages 910-911

  Matsuda, Masayuki ^a,b   Miki, Jun ^a   Oguchi, Kenya ^a   Tabata, Kenichi ^a   Ikeda, Shu Ichi ^b  

^a Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Creatine kinase; Diffuse fasciitis with eosinophilia; Magnetic resonance imaging; Muscle biopsy

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG COST; FASCIITIS; FEMALE; FEVER; GLAUCOMA; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MIXED CONNECTIVE TISSUE DISEASE; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OUTCOMES RESEARCH; PHYSICAL EXAMINATION; PNEUMONIA; RAYNAUD PHENOMENON; SCINTIGRAPHY;

EID: 0141927385     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.910     Document Type: Article

References (5)

1. Wigley FM. Systemic sclerosis. Clinical features. in: Rheumatology. 2nd ed. Klippel JH, Dieppe PA, Eds. Mosby, London, 1998: 7.9.1-14.
2. Hübscher O. Pattern recognition in arthritis. in: Rheumatology. 2nd ed. Klippel JH, Dieppe PA, Eds. Mosby, London, 1998: 2.3.1-6.
3. Kasukawa R, Tojo T, Miyawaki S, et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. in: Mixed connective tissue disease and antinuclear antibodies. Kasukawa R, Sharp GC, Eds. Excerpta Medica, Amsterdam, 1987: 41-47.
4. Ulmer A, Kotter I, Pfaff A, Fierlbeck G. Efficacy of pulsed intravenous immunoglobulin therapy in mixed connective tissue disease. J Am Acad Dermatol 46: 123-127, 2002.
5. Dalakas MC. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51 (Suppl): S2-8, 1998.